Pancrelipase Market Set to Surge by 2037
The Pancrelipase Market was valued at USD 2.3 billion in 2024 and is anticipated to surpass USD 4.1 billion by 2037, expanding at a Compound Annual Growth Rate (CAGR) of 5% over the forecast period (2025–2037). This growth is fueled by the increasing prevalence of pancreatic exocrine insufficiency (PEI), expanding awareness of digestive enzyme therapies, and advancements in pharmaceutical formulations.
Pancrelipase Industry Demand
- Read more about Pancrelipase Market Set to Surge by 2037
- Log in or register to post comments